3rd Meridian Clinical trials are a kind of scientific forum of the emulators from USA’s pharmaceutical and biotechnology site. Meridian Clinical Trials assists in approaching the most renovated industry trends, awareness, and analysis. Being a technology-driven organization, our leading target endures in providing a podium for advanced technological development in the realm of the clinical trial. This pooling of knowledge compensates the crowd’s overall performance, operations perfection, and clinical trials’ achievement quota. This podium is a merger of Exhibitions, presentations, and confrontation with the service providers. Meridian Clinical Trials is a terminate point for industry experts from private companies, governmental organizations, universities, and nonprofits.

Meridian Clinical Trials - Joe
Gene Dolgoff
CEO / CTO
Currently developing: Holographic Energy Teleportation and AdvaNan nanoparticles at Holobeam Technologies for advanced disease diagnosis and treatment, including Covid-19. and cancer. www.holobeamtech.com
Meridian Clinical Trials - Kimberly-Guede
Chris Min
VP, Head of Medical and Clinical Development
Chris is a board-certified neurologist and physician-scientist focused on the development of novel treatments for neurodegenerative diseases
Meridian Clinical Trials Paul-TanPiengco
Oscar Segurado
Chief Medical Officer
Oscar is Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira).
Meridian Clinical Trials Paul-TanPiengco
Nick Damiano
Co-Founder & CEO
Nick Damiano has spent his career as a healthcare entrepreneur, innovator, and leader
Meridian Clinical Trials Paul-TanPiengco
Alice Drumheller
Vice President Clinical Operations
Sensei Biotherapeutics is an innovator in the field of next-generation cancer immunotherapies.
Meridian Clinical Trials Paul-TanPiengco
Arthur P. Bollon
Chairman, Founder & CEO
Chairman & CEO of VITRUVIAN BioMedical, Inc. which is developing an Alzheimer Disease Blood Test and Therapeutic Vaccine targeting both ABeta and TAU.
Vuong Trieu
Vuong Trieu
Chairman & CEO
Dr. Trieu, an expert in pharmaceutical development, currently serves as CEO/Chairman of Oncotelic Inc.. Previously he was President and CEO of Igdrasol- developer of 2nd generation Abraxane
Meridian Clinical Trials Paul-TanPiengco
Venkateswarlu (Venkat) Nelabhotla
CEO & Board Member
Venkat brings a very rich and global experience of more than 25 years, successfully leading organizations in the biotech and cosmeceutics businesses.
Meridian Clinical Trials - Joe
Frank Leu (呂伯藩)
CEO
Co-Founder; 13 years in specialty biopharm leadership roles from R&D to executive
Reginald Hooks
Reginald Hooks
Associate Director, Clinical Operations
Mr. Hooks has been active in clinical research since 2004, beginning at the Departments of Medicine, and Biostatistics and Epidemiology at the University of Oklahoma Health Sciences Center.
Nik Tezapsidis
President & CEO
Experienced Chief Executive Officer with a demonstrated history of working in the biotechnology industry.
Meridian Clinical Trials - Mct
Gurdyal Kalsi
Chief Medical Officer
Entrepreneurial seasoned executive, strategic leader across all stages of product development, licensure and commercialization

DE-risking Phase 3 Clinical Studies in phase 2;case study from Alzheimer and Parkinson

Drivers of Clinical Development Success in Gene Therapy

Overcoming Challenges to accelerate Clinical trails in rare disease.Two case studies.

Coping with ongoing Challenges in coduct of clinical operation, Increasing Acceleration

Harnessing Digital Health technologies: To accelerate Virtual Clinical trail adoption indutrsywide

COVID19 therapeutics: Opportunities & challenges

Chosing an outsourcing Strategy for Start up Pharma/Biotech Organizations

Holistic Data Review: challenges faced by data managers

From Shark to man:treating the gut-brain axis of Parkinson's Disease

Alzheimer's Clinical Trials: Patient Recruitment, interventions, methodology.

Rare Disease / Orphan Disease clinical trial design issue & options for the study of rare disease.

Running COVID-19 Trails in current hypercompetitive environment.

A startups journey from scratch to clinical trials.

Advance Data Management: Data to improve study design & execution

Best practice for managing medical devices trails accross different global regions.

Orphan Drug development using 505(b)2 Pathway.

A new Approach to treating COVID-19 using monoconal antibodies with nanoparticle and EXTERNALLY energy without side effects.

Personal

Lorem ipsum dolor sit amet.

Vestibulum vitae orci tortor.

Ea movet saperet rationibus.

Usu dictas imperdiet eu.

Enter your Google Map API from the Theme Settings panel.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Photos
Event Details
Sponsors